Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Augmentation des complications sanitaires graves lors de l’usage non-médical du protoxyde d’azote en France.
Association française des centres d’addictovigilance; Micallef J, Mallaret M, Lapeyre-Mestre M, Daveluy A, Victorri-Vigneau C, Peyrière H, Debruyne D, Deheul S, Bordet R, Chevallier C, Perault-Pochat MC, Le Boisselier R, Libert F, Chaouachi L, Gillet P. Association française des centres d’addictovigilance, et al. Among authors: debruyne d. Therapie. 2021 Jan-Feb;76(1):53-54. doi: 10.1016/j.therap.2020.01.001. Epub 2020 Jan 17. Therapie. 2021. PMID: 32005483 French. No abstract available.
New synthetic drugs in addictovigilance.
Chavant F, Boucher A, Le Boisselier R, Deheul S, Debruyne D. Chavant F, et al. Among authors: debruyne d. Therapie. 2015 Mar-Apr;70(2):167-89. doi: 10.2515/therapie/2015001. Epub 2015 Apr 9. Therapie. 2015. PMID: 25858573 Free article. English, French.
Warning on increased serious health complications related to non-medical use of nitrous oxide.
French Association of Addictovigilance Centres; Micallef J, Mallaret M, Lapeyre-Mestre M, Daveluy A, Victorri-Vigneau C, Peyrière H, Debruyne D, Deheul S, Bordet R, Chevallier C, Perault-Pochat MC, Le Boisselier R, Libert F, Chaouachi L, Gillet P. French Association of Addictovigilance Centres, et al. Among authors: debruyne d. Therapie. 2021 Sep-Oct;76(5):478-479. doi: 10.1016/j.therap.2020.01.002. Epub 2020 Jan 17. Therapie. 2021. PMID: 32063400 No abstract available.
[Mephedrone: a designer drug of recent use in France].
Debruyne D, Courné MA, Le Boisselier R, Djezzar S, Gérardin M, Boucher A, Karila L, Coquerel A, Mallaret M. Debruyne D, et al. Therapie. 2010 Nov-Dec;65(6):519-24. doi: 10.2515/therapie/2010077. Epub 2010 Dec 23. Therapie. 2010. PMID: 21176758 Review. French.
[The current aspects of the use of ecstasy/MDMA in France].
Spadari M, Batisse A, Guerlais M, Boucher A, Daveluy A, Le Boisselier R, Gibaja V, Eiden C, Lepelley M, Roussin A, Deheul S, Frauger E, Debruyne D. Spadari M, et al. Among authors: debruyne d. Therapie. 2016 Dec;71(6):553-562. doi: 10.1016/j.therap.2016.05.005. Epub 2016 Jun 7. Therapie. 2016. PMID: 27371364 French.
[Use of synthetic substances in France and in Europe].
Debruyne D, Monzon E, Perino J, Haramburu F, Daveluy A, Lazès-Charmetant A, Giraudon I. Debruyne D, et al. Therapie. 2021 May-Jun;76(3):221-228. doi: 10.1016/j.therap.2020.07.005. Epub 2020 Jul 15. Therapie. 2021. PMID: 32859404 French.
[Anabol (methandienone): evidence of an illicit use in France].
Le Boisselier R, Debruyne D, Auclair V, Gambier N, Coquerel A. Le Boisselier R, et al. Among authors: debruyne d. Therapie. 2004 Sep-Oct;59(5):555-8. doi: 10.2515/therapie:2004094. Therapie. 2004. PMID: 15648309 French. No abstract available.
[Abuse of gammabutyrolactone (GBL): a case report].
Le Boisselier R, Paillet-Loilier M, Buléon C, Debruyne D, Coquerel A. Le Boisselier R, et al. Among authors: debruyne d. Therapie. 2011 Mar-Apr;66(2):175-7. doi: 10.2515/therapie/2011017. Therapie. 2011. PMID: 23189338 French. No abstract available.
121 results